Viridian Therapeutics, Inc.
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Viridian Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 177
- −1 vs. Q4 2024
- Shares held
- 91.4M
- +1.00M (+1.1%) vs. Q4 2024
- Total value
- $1.23B
- −$500.6M (−28.9%) vs. Q4 2024
- New holders
- 26
- 67 more added
- Sold out
- 27
- 55 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $2.50B |
| Q1 2026 | 225 | $2.21B |
| Q4 2025 | 229 | $3.36B |
| Q3 2025 | 169 | $2.01B |
| Q2 2025 | 171 | $1.32B |
| Q1 2025 | 177 | $1.23B |
| Q4 2024 | 179 | $1.75B |
| Q3 2024 | 165 | $1.98B |
| Q2 2024 | 138 | $906.2M |
| Q1 2024 | 136 | $1.24B |
| Q4 2023 | 132 | $1.31B |
| Q3 2023 | 124 | $769.9M |
| Q2 2023 | 128 | $1.12B |
| Q1 2023 | 135 | $1.10B |
| Q4 2022 | 122 | $1.21B |
| Q3 2022 | 105 | $778.5M |
| Q2 2022 | 84 | $327.7M |
| Q1 2022 | 72 | $460.9M |
| Q4 2021 | 55 | $459.8M |
| Q3 2021 | 39 | $223.7M |
| Q2 2021 | 26 | $109.8M |
| Q1 2021 | 33 | $84.5M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Oconnor LLC | 107,088 | $1.44M | 0.03% | +62,488+140.1% | Added |
| Swiss National Bank | 107,500 | $1.45M | 0.00% | −5,100−4.5% | Reduced |
| Susquehanna International Group, LLP | 109,984 | $1.48M | 0.00% | +14,119+14.7% | Added |
| Dark Forest Capital Management LP | 113,646 | $1.53M | 0.07% | +100,361+755.4% | Added |
| J. Goldman & Co LP | 118,594 | $1.60M | 0.06% | −60,902−33.9% | Reduced |
| American Century Companies Inc | 122,892 | $1.66M | 0.00% | +9,330+8.2% | Added |
| Barclays PLC | 124,063 | $1.67M | 0.00% | −33,797−21.4% | Reduced |
| UBS Asset Management Americas Inc | 130,570 | $1.76M | 0.00% | +14,788+12.8% | Added |
| Citigroup Inc | 135,414 | $1.83M | 0.00% | −507−0.4% | Reduced |
| BNP Paribas Arbitrage, SA | 138,864 | $1.87M | 0.00% | −64,989−31.9% | Reduced |
| Boothbay Fund Management, LLC | 145,318 | $1.96M | 0.07% | +7,400+5.4% | Added |
| Artia Global Partners LP | 160,000 | $2.16M | 0.63% | +60,000+60.0% | Added |
| Macquarie Group Ltd | 160,948 | $2.17M | 0.00% | +18,555+13.0% | Added |
| Diadema Partners LP | 162,063 | $2.18M | 1.75% | +112,585+227.5% | Added |
| Susquehanna Fundamental Investments, LLC | 177,166 | $2.39M | 0.04% | +177,166 | New |
| Bank of America Corp | 180,123 | $2.43M | 0.00% | −66,984−27.1% | Reduced |
| HighVista Strategies LLC | 180,551 | $2.43M | 0.94% | +25,988+16.8% | Added |
| Two Sigma Advisers, LP | 193,300 | $2.61M | 0.01% | −142,269−42.4% | Reduced |
| Bank of New York Mellon Corp | 198,177 | $2.67M | 0.00% | +1,655+0.8% | Added |
| Russell Investments Group, Ltd. | 198,258 | $2.67M | 0.00% | −181,338−47.8% | Reduced |
| Hennion & Walsh Asset Management, Inc. | 199,193 | $2.69M | 0.12% | −11,706−5.6% | Reduced |
| Point72 Asset Management, L.P. | 204,702 | $2.76M | 0.01% | +204,702 | New |
| Kopp Family Office, LLC | 205,407 | $2.77M | 1.91% | 00.0% | Unchanged |
| Principal Financial Group Inc | 208,836 | $2.82M | 0.00% | +30,392+17.0% | Added |
| Exome Asset Management LLC | 217,294 | $2.93M | 2.62% | +217,294 | New |
| Two Sigma Investments, LP | 222,399 | $3.00M | 0.01% | −202,138−47.6% | Reduced |
| Nuveen, LLC | 248,628 | $3.35M | 0.00% | +248,628 | New |
| Wellington Management Group LLP | 249,170 | $3.36M | 0.00% | +24,686+11.0% | Added |
| Millennium Management LLC | 297,966 | $4.02M | 0.00% | −68,006−18.6% | Reduced |
| JPMorgan Chase & Co | 298,550 | $4.02M | 0.00% | −5,784−1.9% | Reduced |
| Raymond James Financial Inc | 318,240 | $4.29M | 0.00% | +4,453+1.4% | Added |
| Renaissance Technologies LLC | 320,300 | $4.32M | 0.01% | −50,900−13.7% | Reduced |
| Morgan Stanley | 341,795 | $4.61M | 0.00% | −397,345−53.8% | Reduced |
| Panagora Asset Management Inc | 354,739 | $4.78M | 0.02% | +101,717+40.2% | Added |
| Rice Hall James & Associates, LLC | 362,893 | $4.89M | 0.29% | +309,518+579.9% | Added |
| Affinity Asset Advisors, LLC | 390,000 | $5.26M | 0.82% | +230,386+144.3% | Added |
| Deutsche Bank AG | 396,808 | $5.35M | 0.00% | −6,066−1.5% | Reduced |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 423,272 | $5.71M | 1.18% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 450,000 | $6.07M | 1.32% | −420,000−48.3% | Reduced |
| Ikarian Capital, LLC | 494,949 | $6.67M | 2.17% | +25,000+5.3% | Added |
| Yiheng Capital Management, L.P. | 500,261 | $6.74M | 2.37% | −250,000−33.3% | Reduced |
| UBS Group AG | 504,185 | $6.80M | 0.00% | −7,886−1.5% | Reduced |
| Fisher Asset Management, LLC | 537,024 | $7.24M | 0.00% | +18,997+3.7% | Added |
| Victory Capital Management Inc | 552,850 | $7.45M | 0.01% | +142,410+34.7% | Added |
| Charles Schwab Investment Management Inc | 565,963 | $7.63M | 0.00% | −9,107−1.6% | Reduced |
| Rosalind Advisors, Inc. | 595,000 | $8.02M | 3.91% | +595,000 | New |
| Perceptive Advisors LLC | 659,662 | $8.89M | 0.32% | −826,846−55.6% | Reduced |
| Northern Trust Corp | 702,517 | $9.47M | 0.00% | +8,375+1.2% | Added |
| 5AM Venture Management, LLC | 736,595 | $9.93M | 3.76% | 00.0% | Unchanged |
| Great Point Partners LLC | 750,000 | $10.1M | 5.50% | 00.0% | Unchanged |
| Woodline Partners LP | 813,647 | $11.0M | 0.07% | 00.0% | Unchanged |
| Candriam Luxembourg S.C.A. | 880,430 | $11.9M | 0.07% | +149,209+20.4% | Added |
| Vivo Capital, LLC | 982,576 | $13.2M | 1.75% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 1,064,506 | $14.3M | 1.70% | −23,128−2.1% | Reduced |
| Marshall Wace, LLP | 1,084,040 | $14.6M | 0.02% | +1,084,040 | New |
| Adage Capital Partners GP, L.L.C. | 1,114,586 | $15.0M | 0.03% | −555,414−33.3% | Reduced |
| Goldman Sachs Group Inc | 1,231,092 | $16.6M | 0.00% | +310,998+33.8% | Added |
| Pictet Asset Management Holding SA | 1,248,721 | $16.8M | 0.02% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 1,270,481 | $17.1M | 0.17% | −605,395−32.3% | Reduced |
| Loomis Sayles & Co L P | 1,370,356 | $18.5M | 0.03% | −30,025−2.1% | Reduced |
| Eversept Partners, LP | 1,377,674 | $18.6M | 2.10% | +597,676+76.6% | Added |
| Price T Rowe Associates Inc | 1,688,129 | $22.8M | 0.00% | +361,318+27.2% | Added |
| Geode Capital Management, LLC | 1,720,525 | $23.2M | 0.00% | +61,545+3.7% | Added |
| Alliancebernstein L.P. | 2,021,619 | $27.3M | 0.01% | −265,375−11.6% | Reduced |
| Maverick Capital LtdSuperinvestorMaverick Capital | 2,061,274 | $27.8M | 0.50% | +7,368+0.4% | Added |
| Paradigm Biocapital Advisors LP | 2,095,079 | $28.2M | 1.30% | +275,000+15.1% | Added |
| Novo Holdings A/S | 2,250,300 | $30.3M | 2.31% | +3000.0% | Added |
| Tang Capital Management LLC | 2,792,925 | $37.6M | 2.08% | +300,000+12.0% | Added |
| State Street Corp | 2,865,500 | $38.6M | 0.00% | −657,066−18.7% | Reduced |
| Fairmount Funds Management LLC | 3,445,813 | $46.4M | 7.21% | 00.0% | Unchanged |
| Commodore Capital LP | 3,600,000 | $48.5M | 3.58% | +1,200,000+50.0% | Added |
| VR Adviser, LLC | 3,882,709 | $52.3M | 4.45% | 00.0% | Unchanged |
| Vanguard Group Inc | 4,563,100 | $61.5M | 0.00% | −31,949−0.7% | Reduced |
| Kynam Capital Management, LP | 4,700,000 | $63.4M | 5.42% | +1,373,738+41.3% | Added |
| Deep Track Capital, LP | 5,380,449 | $72.5M | 2.35% | +857,708+19.0% | Added |
| BlackRock, Inc. | 5,708,110 | $76.9M | 0.00% | −50,467−0.9% | Reduced |
| FMR LLC | 12,222,986 | $164.8M | 0.01% | +341,074+2.9% | Added |
| Cutter Capital Management, LP | 0 | $0 | 0.00% | −628,677−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −459,588−100.0% | Sold out |
| Crestline Management, LP | 0 | $0 | 0.00% | −200,857−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −130,721−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −120,065−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Concentric Capital Strategies, LP | 0 | $0 | 0.00% | −88,527−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −56,760−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −55,924−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −47,995−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −45,500−100.0% | Sold out |
| Bryce Point Capital, LLC | 0 | $0 | 0.00% | −44,063−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −38,367−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −34,094−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −28,809−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −25,724−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −25,700−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −20,143−100.0% | Sold out |
| Farringdon Capital, Ltd. | 0 | $0 | 0.00% | −17,152−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −13,473−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −12,702−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −12,236−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −11,332−100.0% | Sold out |